Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs114211674 | chr5:179484518 | A/C | 1.35E-5 | 176 | 24.23 | 32.15 | 25.17 | KM Plot |
PCPG | rs114285567 | chr3:39772303 | G/T | 9.42E-8 | 175 | 25.77 | 19.88 | 19.87 | KM Plot |
PCPG | rs114335836 | chr16:89974733 | C/T | 0.00018 | 173 | 25.87 | 20.28 | 36.37 | KM Plot |
PCPG | rs11443636 | chr11:89958532 | C/CA | 0.000117 | 175 | 27.2 | 19.07 | 14.73 | KM Plot |
PCPG | rs114436460 | chr10:69710484 | G/A | 0 | 176 | 25.87 | 18.2 | 2.28 | KM Plot |
PCPG | rs11444598 | chr2:242569791 | C/CA | 1.07E-10 | 172 | 25.67 | 21.9 | 10.3 | KM Plot |
PCPG | rs11453906 | chr3:182618390 | G/GA | 1.18E-5 | 173 | 25.87 | 26.88 | 11.78 | KM Plot |
PCPG | rs114606309 | chr1:36924630 | G/C | 8.21E-5 | 175 | 25.53 | 25.97 | 10.3 | KM Plot |
PCPG | rs11463497 | chr17:3287288 | C/CA | 0.000175 | 176 | 18.1 | 25.43 | 26.88 | KM Plot |
PCPG | rs114793754 | chr7:105152162 | G/C | 5.56E-5 | 177 | 20.17 | 29.43 | 2.28 | KM Plot |
PCPG | rs114865717 | chr7:105158526 | C/T | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs114927373 | chr10:69738535 | C/T | 0 | 177 | 25.87 | 18.2 | 2.28 | KM Plot |
PCPG | rs115219347 | chr2:241507613 | G/A | 2.62E-7 | 174 | 26.57 | 20.25 | 7.2 | KM Plot |
PCPG | rs115270507 | chr3:115555527 | C/T | 1.09E-5 | 176 | 25.2 | 26.37 | 13.75 | KM Plot |
PCPG | rs11527803 | chr10:50552555 | A/T | 3.62E-6 | 178 | 24.52 | 34.37 | 25.17 | KM Plot |